Skip to main content

Soundsafe Care

Soundsafe Care develops a medical device that integrates robotics and ultrasound technologies for cancer treatment. This system is designed to perform tumor treatment without requiring incisions or introducing toxicity. The company focuses on advancing surgical standards in oncology care through this innovative technology.

Pontedera, Italy · HQ
Founded 2023101K+ followers
  • Healthcare Technology
  • Medical Devices
  • Robotics
Updated 4 months ago

Funding

Raised to date

€1.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Est. $1.9M

across 1 round

R

€1.8M · Seed

Announced Nov 2023

Disclosed cumulative: $1.9M

Founders

2 founders

Andrea Mariani

Pisa, Italy

Chief Executive Officer & Co-founder

Profile summary: Scuola Superiore Sant'Anna • Postdoctoral Researcher · PhD at Scuola Superiore Sant'Anna

Laura Morchi

Pisa, Italy

Co-founder

Profile summary: TECNALIA Research & Innovation • Visiting Research Scientist · PhD at Scuola Superiore Sant'Anna

Product

Problem

Traditional tumor treatments often involve invasive surgical procedures or systemic therapies like chemotherapy, which can lead to significant side effects and prolonged recovery times. These methods may not be suitable for all patients, particularly those with tumors in difficult-to-reach locations or those who are not strong candidates for surgery.

Solution

Soundsafe Care is developing a robotic ultrasound system that enables non-invasive tumor treatment, eliminating the need for incisions and reducing toxic side effects. The system uses focused ultrasound waves to precisely target and ablate tumors, offering a safer and more effective alternative to traditional surgical methods. The robotic platform allows for accurate positioning and real-time monitoring of the treatment, ensuring that the ultrasound energy is delivered precisely to the tumor while sparing surrounding healthy tissue. This approach aims to improve patient outcomes, reduce recovery times, and enhance the overall quality of life for individuals undergoing cancer treatment.

Target Audience

The primary target audience includes hospitals, cancer treatment centers, and medical professionals specializing in oncology and surgical robotics.

Features

  • Robotic platform for precise positioning and targeting of tumors
  • Focused ultrasound technology for non-invasive tumor ablation
  • Real-time monitoring and feedback to ensure accurate treatment delivery
  • Compatibility with various imaging modalities for enhanced visualization
  • Customizable treatment parameters to adapt to different tumor types and locations
  • Integration with treatment planning software for optimized therapy delivery
This profile is AI-generated and may contain inaccuracies.